Upgrade to SI Premium - Free Trial

KeyBanc on Oracle (ORCL): 'Execution Delivers In-period Upside'

March 11, 2026 8:07 AM
KeyBanc analyst Jackson Ader reiterated an Overweight rating and $300.00 price target on Oracle (NYSE: ORCL).The analyst commented: "Execution Delivers ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments